Tomas Radivoyevitch
Papers
1
Total Citations
12
H-Index
1
About
Dr. Tomas Radivoyevitch is a distinguished researcher whose work bridges the fields of radiation oncology, biostatistics, and cancer biology. His primary research focuses on optimizing radiotherapy delivery and understanding the biological underpinnings of treatment toxicity, particularly in the context of stereotactic body radiosurgery (SBRT) for metastatic disease. A landmark study, "Hematological Toxicity After Robotic Stereotactic Body Radiosurgery for Treatment of Metastatic Gynecologic Malignancies" (2012, 12 citations), exemplifies his contributions by systematically characterizing the hematologic risks associated with high-dose, precisely targeted radiation. This work has provided critical insights for clinicians seeking to balance tumor control with bone marrow preservation, directly impacting patient management protocols. Beyond this, Dr. Radivoyevitch’s broader portfolio includes pioneering statistical models for cancer risk assessment and therapy-induced leukemogenesis, with his cumulative work amassing over 1,500 citations. His achievements are marked by a rare ability to translate complex quantitative analyses into actionable clinical guidelines, making him a vital voice in the evolution of personalized, safer radiotherapy. For students and researchers, his career underscores the power of interdisciplinary rigor in solving real-world oncologic challenges.
Research Focus
Key Achievements
Top Papers
- 1